IBB
335.97
-2.15
-0.64%
XBI
86.23
-0.51
-0.59%
NASDAQ
6624.22
+0.56
+0.01%
S&P500
2561.26
+1.9
+0.07%
^STOXX50E
3619.65
+11.88
+0.33%
AB.PA
8.75
-0.1
-1.13%
ADOC.PA
16.26
-0.4
-2.40%
ALCLS.PA
23.2
-0.8
-3.33%
DBV.PA
82.37
+0.31
+0.38%
ERYP.PA
25.84
-1
-3.73%
GNFT.PA
22.25
-0.24
-1.07%
ALHYG.PA
0.58
0.00
0.00%
IPH.PA
10.3
+0.02
+0.19%
NANO.PA
16.66
-0.04
-0.24%
ALNEV.PA
0.57
0.00
0.00%
COX.PA
9.163
-0.207
-2.209%
ALNOV.PA
0.69
-0.12
-14.81%
TNG.PA
3.36
+0.02
+0.60%
TXCL.PA
1.7
0.00
0.00%
VLA.PA
2.8
-0.02
-0.71%
IBB
335.97
-2.15
-0.64%
XBI
86.23
-0.51
-0.59%
NASDAQ
6624.22
+0.56
+0.01%
S&P500
2561.26
+1.9
+0.07%
^STOXX50E
3619.65
+11.88
+0.33%
AB.PA
8.75
-0.1
-1.13%
ADOC.PA
16.26
-0.4
-2.40%
ALCLS.PA
23.2
-0.8
-3.33%
DBV.PA
82.37
+0.31
+0.38%
ERYP.PA
25.84
-1
-3.73%
GNFT.PA
22.25
-0.24
-1.07%
ALHYG.PA
0.58
0.00
0.00%
IPH.PA
10.3
+0.02
+0.19%
NANO.PA
16.66
-0.04
-0.24%
ALNEV.PA
0.57
0.00
0.00%
COX.PA
9.163
-0.207
-2.209%
ALNOV.PA
0.69
-0.12
-14.81%
TNG.PA
3.36
+0.02
+0.60%
TXCL.PA
1.7
0.00
0.00%
VLA.PA
2.8
-0.02
-0.71%
News

Valneva

Valneva et GSK, une histoire qui dure !

8 février 2016 // 1 Comment

GlaxoSmithKline, qui avait l'un des premiers à s'intéresser à la plate-forme EB66 permettant de produire des vaccins en bioréacteur à partir de lignées cellulaires [...]
1 2 3
s2Member®